These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9865302)

  • 41. Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction.
    Khauli RB; Houjaij A; Sawah S; El-Hout Y; Medawwar W; Hussein M; Habbal A; Daouk M; Uwaydah M; Maacaron H; Abdelnoor A
    Transplant Proc; 2005 Sep; 37(7):3031-3. PubMed ID: 16213295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
    Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C
    Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical study of FK 506 in renal transplant recipients.
    Youhua Z; Zhinlian M; Liming W
    Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900
    [No Abstract]   [Full Text] [Related]  

  • 45. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
    Kovac D; Kotnik V; Kandus A
    Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
    Nowacka-Cieciura E; Soluch L; Cieciura T; Lewandowska D; Durlik M; Shaibani B; Serafinowicz A; Szmidt J; Rowiński W; Lao M
    Transplant Proc; 2000 Sep; 32(6):1339-43. PubMed ID: 10995973
    [No Abstract]   [Full Text] [Related]  

  • 47. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish Group. Spanish Group of the CellCept Study.
    Puig i Marí JM
    Transplant Proc; 1999 Sep; 31(6):2256-8. PubMed ID: 10500566
    [No Abstract]   [Full Text] [Related]  

  • 49. Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.
    Campistol JM; Mazuecos A; Segura J; Osuna A; Herrero JC; Andres A; Oppenheimer F; Gomez de la Camara A; Martinez MA; Morales JM
    Transplant Proc; 1999 Sep; 31(6):2267-9. PubMed ID: 10500571
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
    Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML
    Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488
    [No Abstract]   [Full Text] [Related]  

  • 51. Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups.
    Cho S; Hodge E; Navarro M
    Transplant Proc; 1999; 31(1-2):322-3. PubMed ID: 10083126
    [No Abstract]   [Full Text] [Related]  

  • 52. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
    Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
    [No Abstract]   [Full Text] [Related]  

  • 53. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
    Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
    Meier-Kriesche HU; Friedman G; Jacobs M; Mulgaonkar S; Vaghela M; Kaplan B
    Transplantation; 1999 Nov; 68(10):1496-502. PubMed ID: 10589946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
    Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
    Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
    [No Abstract]   [Full Text] [Related]  

  • 56. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
    Sells RA; Bakran A; Brown MW; Grinyo J; Hammad A; Hyatt D; Owens G
    Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
    [No Abstract]   [Full Text] [Related]  

  • 59. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

  • 60. Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients.
    Carmellini M; Vistoli F; Bellini R; Boggi U; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1999; 31(1-2):1162-4. PubMed ID: 10083519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.